Literature DB >> 24369317

The history of 5-ASA compounds and their use in ulcerative colitis--trailblazing discoveries in gastroenterology.

John Mayberry1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24369317

Source DB:  PubMed          Journal:  J Gastrointestin Liver Dis        ISSN： 1841-8724            Impact factor:   2.008


× No keyword cloud information.
  4 in total

Review 1.  Formyl peptide receptor 2 as a potential therapeutic target for inflammatory bowel disease.

Authors:  Wen-Sheng Yang; Jing-Lin Wang; Wei Wu; Guang-Fei Wang; Jun Yan; Qing Liu; Xiao-Yan Wu; Qing-Tong Zhou; De-Hua Yang; Ming-Wei Wang; Zhi-Ping Li
Journal:  Acta Pharmacol Sin       Date:  2022-07-15       Impact factor: 7.169

Review 2.  Staging Pouch Surgery in Ulcerative Colitis in the Biological Era.

Authors:  Anton Risto; Maie Abdalla; Pär Myrelid
Journal:  Clin Colon Rectal Surg       Date:  2022-01-17

3.  Adherence to Asacol once daily versus divided regimen for maintenance therapy in ulcerative colitis: a prospective, multicenter, randomized study.

Authors:  Soo-Kyung Park; Sang Hyun Park; Chang Soo Eun; Geom Seog Seo; Jong Pil Im; Tae Oh Kim; Dong-Il Park
Journal:  Intest Res       Date:  2019-02-08

Review 4.  Tackling the Threat of Cancer Due to Pathobionts Producing Colibactin: Is Mesalamine the Magic Bullet?

Authors:  Min Tang-Fichaux; Priscilla Branchu; Jean-Philippe Nougayrède; Eric Oswald
Journal:  Toxins (Basel)       Date:  2021-12-14       Impact factor: 4.546
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.